Viromed Medical AG (XTER:VME) Total Equity: €10.47 Mil (As of Dec. 2025)


XTER:VME Viromed Medical AG XTER:VME
15 GF Score
Price €6.75
! 5 Warning Signs
View Full Analysis

What is Viromed Medical AG Total Equity?

Viromed Medical AG XTER:VME -4.93% 15 Total Equity is €10.47 Mil as of Dec. 2025. GuruFocus rates XTER:VME with a GF Score™ of 15/100. The stock has 5 warning signs investors should review.

Viromed Medical AG's total equity for the quarter that ended in Dec. 2025 was €10.47 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Viromed Medical AG Total Equity Historical Data

* Premium members only.

The historical data trend for Viromed Medical AG's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viromed Medical AG Total Equity Chart

Viromed Medical AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
0.25 20.08 19.97 9.27 10.47

Viromed Medical AG Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only 19.97 19.82 9.27 20.47 10.47
XTER:VME
15GF Score
Viromed Medical AG XTER:VME
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viromed Medical AG Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Viromed Medical AG's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=13.914-3.44
=10.47

Viromed Medical AG's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=13.914-3.44
=10.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €10.47 Mil mean?
Viromed Medical AG (XTER:VME) has a Total Equity of €10.47 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Viromed Medical AG and its competitors.
Is Viromed Medical AG's Total Equity too high?
Viromed Medical AG's current Total Equity is €10.47 Mil. Overall, Viromed Medical AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Total Equity compare to ABT and SYK?
Viromed Medical AG's Total Equity of €10.47 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Viromed Medical AG and its competitors. Viromed Medical AG's current Total Equity is €10.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current Total Equity of €10.47 Mil. The current Total Equity is €10.47 Mil. Viromed Medical AG's overall GF Score™ is 15/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current Total Equity is €10.47 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viromed Medical AG Business Description

Address Hauptstrasse 105, Rellingen, Pinneberg, SH, DEU, 25462
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
15GF Score

Get the complete analysis for XTER:VME

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.75
Price